Navigation Links
Prix Galien winners published in Annals of the New York Academy of Sciences
Date:4/4/2011

Scholarly papers from the winners and finalists of the 2010 Prix Galien USA and Prix Galien International awards have been published as a special issue of Annals of the New York Academy of Sciences. The Prix Galien, regarded as the Nobel Prize in biopharmaceutical research, recognizes outstanding achievements in improving the global human condition through the development of innovative drugs and treatments.

Established in 1970, Prix Galien is the most prestigious award of its kind in eleven countries. The awards include the Prix Galien Humanitarian Award, the International Prix Galien award, and Prix Galien USA, which has three subcategories, Best Medical Technology, Best Pharmaceutical Agent and Best Biotechnology Product.

"I thank the many leading companies and eminent scientists and scholars whose pioneering work saves lives and raises standards of living," said Ban Ki-moon, Secretary General of the United Nations, who spoke at the awards ceremony in New York City. "I thank the Galien Foundation for bringing us together and for recognizing that a healthier world is a safer and more just world."

Also present were Philippe Douste-Blazy, President of UNITAID, and former US President Bill Clinton, now President of the Clinton Health Access Initiative; each was awarded the Prix Galien Pro Bono Humanitarian Award for their effort to find treatments for HIV/AIDS, malaria, and tuberculosis.

"I'm particularly grateful to receive this award from this group on behalf of all the people who work in our foundation and work with UNITAID," said Clinton, "because I believe that the biomedical challenges we face in the 21st century cannot be successfully addressed unless we resolve the legitimate differences that have existed among the large pharmaceutical companies, the generic companies, the governments struggling to keep their own people alive, and the developed nations struggling to do the right thing by their own companies and contributing money to keep people alive."

Best Medical Technology was awarded to Luminex Corporation for xTAG. "Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel" led by Dr Nancy Krunic.

Best Biotechnology Product was awarded to Merck & Co, Inc. for RotaTeq. "Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine" led by Dr Michelle Goveia.

Best Pharmaceutical Agent was awarded to Novartis for Coartem. "Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria" led by Gilbert Lefvre.

Prix Galien International Award was awarded to Amgen for Nplate and Bayer Schering Pharma for Xarelto. "The development of romiplostim for patients with immune thrombocytopenia" by Graham Molineux (Nplate) and "The discovery and development of rivaroxaban" led by Frank Misselwitz (Xarelto).

"Annals of the New York Academy of Sciences is proud to publish papers that summarize the history and development of advances in pharmaceutical science" said Annals Director and Executive Editor Dr. Douglas Braaten. "We are delighted to partner with Bruno Cohen, Galien Foundation President, to honor the winners and finalists of the Prix Galien awards.

By highlighting these pharmaceutical industry achievements, this special Annals volume continues the tradition established by Prix Galien founder Roland Mehl to honor the most important drugs and treatments which will have a worldwide impact."


'/>"/>

Contact: Ben Norman
Lifesciencenews@wiley.com
44-124-377-0375
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. ASH announces 2010 merit award winners
2. Health Literacy Innovations Announces 1st Annual Health Literacy Innovator Award — Anonymous Donor Offers Prize Money To Winners
3. SNMs Technologist Section announces award winners
4. Intent.com Launches 30 Days of Intentions and Announces Winners of 2010 Intent Web Awards
5. High School Students Well-Schooled In Diversity: Teen Winners of Book Writing Contest Earn College Scholarships and Have Entries Published
6. 2010 OTC National Advertising Award Winners Announced
7. IADR and GSK Consumer Healthcare announce winners of 2010 Innovation in Oral Care Awards
8. NIDA announces 2010 Addiction Science Award winners at Intel ISEF
9. The biggest winners: Summer campers
10. ABBY Winners Announced & Honored with 2010 Innovations in Healthcare(SM) Awards
11. Wharton Business Plan Competition Michelson Grand Prize Winners Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... ... Today, the Centers for Medicare & Medicaid Services (CMS) announced over 359,000 ... in 2017. Clinicians who participate in APMs are paid for the quality of care ... effort to build a system that delivers better care and one in which clinicians ...
(Date:1/19/2017)... ... ... Next week after January 20th, the fear for many is that the ... needs of over 30 million. Many interviews with Dr. Carol Francis at the Los ... were suppose to prioritize. Interviews provided below. , Among those present was ...
(Date:1/19/2017)... ... January 19, 2017 , ... With the cold weather here, many people will have to clear ... when clearing large amounts of snow, but they can be dangerous when used incorrectly. That’s ... Safety Commission for the proper use of snow blowers:, , When ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... engineers, and scientists from around the world, announces the launch of its newly ... and easy portal to research breakthroughs and trending news, vital information on upcoming ...
(Date:1/19/2017)... Melville, New York (PRWEB) , ... January 19, ... ... state–of-the-art high definition dynamic telemedicine solutions, has recently unveiled impressive transportable capabilities with ... this newly designed product is an extension to RMT technology that delivers HD, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis instruments and consumables for the medical ... to discuss its financial results for the third quarter ... will be at 4:15 p.m. ET on Thursday, January ... the third quarter fiscal year 2017 after the market ...
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... , January 19, 2017 ... announced that the U.S. Food and Drug Administration (FDA) ... a New Drug Application (NDA) for SHP465, a long-acting, ... as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). ... or around June 20, 2017, the designated Prescription Drug ...
Breaking Medicine Technology: